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Abstract – Myxoma virus (MYXV), a member of the Poxviridae family, is the agent responsible for
myxomatosis, a fatal disease in the European rabbit (Oryctolagus cuniculus). MYXV has a linear
double-stranded DNA genome that encodes several factors important for evasion from the host immune
system. Among them, four ankyrin (ANK) repeat proteins were identiﬁed: M148R, M149R, M150R and
M-T5. To date, only M150R and M-T5 were studied and characterized as critical virulence factors. This
article presents the ﬁrst characterization of M148R and M149R. Green Fluorescent Protein (GFP) fusions
allowed us to localize them in a viral context. Whereas M149R is only cytoplasmic, interestingly, M148R
is in part located in the nucleolus, a unique feature for an ANK repeat poxviral protein. In order to evaluate
their implication in viral pathogenicity, targeted M148R, M149R, or both deletions were constructed in
the wild type T1 strain of myxoma virus. In vitro infection of rabbit and primate cultured cells as well as
primary rabbit cells allowed us to conclude that M148R and M149R are not likely to be implicated in cell
tropism or host range functions. However, in vivo experiments revealed that they are virulence factors since
after infection of European rabbits with mutant viruses, a delay in the onset of clinical signs, an increase
of survival time and a dramatic decrease in mortality rate were observed. Moreover, histological analysis
suggests that M148R plays a role in the subversion of host inﬂammatory response by MYXV.
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1. INTRODUCTION
Myxoma virus (MYXV), a member of the
Poxviridae family, is the agent responsible
for myxomatosis, a highly lethal disease in
the European rabbit (Oryctolagus cuniculus).
The main anatomical and clinical features of
myxomatosis are a pseudotumoral lesion at the
inoculation site followed by the occurrence of
secondary lesions at cutaneous and visceral
levels, named myxomas [29]. Due to MYXV’s
particular ability to escape and subvert the
host artillery, these lesions are accompanied
by general dysfunction of cellular immunity,
resulting in bacterial super infections of the
respiratory tract culminating in death within
two weeks [29].
* Corresponding author: c.camus@envt.fr
MYXV has a double-stranded DNA
genome of 162kbp [5], with a central region
containing highly conserved enzymatic and
structural genes required for the maintenance
of essential viral functions. Peripheral regions
of the DNA, within and near the inverted
terminal repeats (ITR) at both sides of the
genome, encode nonessential factors that con-
tribute to the modulation of the host response
to infection [29, 31, 32]. Two genes present
near the right ITR, M148R and M149R,
have functions that are still speculative. They
encode 2 of the 4 ankyrin (ANK) repeat-
containing proteins of the MYXV [5, 17].
The ANK repeat is one of the most common,
modular, protein-protein interaction motifs
in nature. This module is involved in a wide
range of cellular functions. The importanceVet. Res. (2009) 40:11 S. Blanié et al.
of the MYXV-ANK-repeat proteins has been
demonstrated: MT-5 is a host-range factor
essential for permissive MYXV infection in
rabbit lymphocytes [18, 34], and Myxoma
Nuclear factor (MNF) seems to interfere with
NF-kappa B (NFB) pathways, leading to
the inhibition of inﬂammatory response [6].
Disruption of either one of these genes results
in dramatic attenuation of myxomatosis in
infected European rabbits. Interestingly,
M148R, M149R, and MNF (M150R) are
located in series on the MYXV genome,
forming a cluster of ANK repeats encoding
genes at the right end of the MYXV genome.
Here we present the ﬁrst characterization
of M148R and M149R. Our data suggest that
they are both virulence factors of MYXV, with
different cellular localizations and acting in
different ways compared to the other ANK
repeat MYXV proteins.
2. MATERIALS AND METHODS
2.1. Cells and viruses
Rabbit kidney cells (RK13; ATCC CCL-37),
RK13 HGPRT− cells (deﬁcient in hypoxanthine-
guanine phosphoribosyl transferase) and Baby
Green Monkey Kidney cells (BGMK) were main-
tained in Dulbecco minimum essential medium
(DMEM) supplemented with 10% fetal calf serum
(FCS). Rabbit peripheral blood mononuclear cells
(PBMC) were isolated and cultured as previously
described [23].The wild type MYXV strain T1 and
the MYXV mutants (MYXV- M148R, MYXV-
 M149R and MYXV- M148R M149R) were
grown in RK13 cells, in DMEM supplemented with
5% FCS.
2.2. Cloning, sequencing and computer analysis
of DNA and protein sequences
DNA sequences were analyzed with DNA
Strider 1.3 software [15] and the BLAST pro-
gram [35]. Searches for ANK repeats were
performed with REP1 [1]; Pfam2 [11]; and
SMART3 [14]; online software packages. Manual
1 http://www.embl-heidelberg.de/∼andrade/papers/
rep/search.html
2 http://pfam.sanger.ac.uk/search
3 http://smart.embl-heidelberg.de/
analysis, according to published consensus pro-
moter sequences [4], was performed to predict
M148R and M149R expression during the infection
cycle.
2.3. RNA extraction and RT-PCR analysis
RK13 cells (2 × 106 cells) were infected with
wild type MYXV strain T1 at a multiplicity of
infection (m.o.i.) of 5. The inoculum was allowed
to adsorb for 1h at 4 ◦C. Total RNA was isolated at
0, 2, 4, 8, 12 and 16h post-infection (p.i.) (Nucleo-
Spin RNA II; Macherey-Nagel, Hoerd, France). In
addition, total RNA was also extracted at 16h p.i.
from mock infected cells and from T1 infected cells
treated with 40g/mL cytosine arabinoside (AraC)
(Sigma, Lyon, France) at the time of infection. All
RNA samples were subjected to DNaseI treatment.
Reverse transcription was performed using oligo-
dT and M-MLV reverse transcriptase (Invitrogen,
Paisley, UK), and followed by PCR analysis
using speciﬁc primers of M148R (5 M148R-BglII
(5 -CGAAGATCTATGGATCACGTAAGCTATT
ACATTGT-3 )a n d3  M148R-PstI (5 -AAACTG
CAGGTAACCGAACGTATCTATGCAAC-3 ))
or M149R (5 M149R-BamHI (5 -CGCGGATCC
GCAATTATGGCCTCGTTGCAT-3 )a n d3  M
149R-PstI (5 -AAACTGCAGCGCACTATTTTGT
ACGGTTTA-3 ) (restriction sites are underlined).
PCR (Expand High Fidelity; Roche, Basel,
Switzerland) were performed over 30 cycles, with a
hybridization temperature of 63 ◦C for each cycle.
A control RT-PCR, in which reverse transcriptase
was omitted during the RT step, was performed
with all samples (not shown).
2.4. Engineering of Green Fluorescent Protein
(GFP) fusions
GFP fusions, under CMV promoter, were
obtained using the pEGFP-F plasmid vector (BD
Biosciences-Clontech, Saint-Germain-en-Laye,
France). The M148R open reading frame was
ampliﬁed by PCR using 5 M148RBglII and
3 M148RPstI. The M149R open reading frame
was ampliﬁed by PCR using 5 M149RBamHI
and 3 M149RPstI. The resulting PCR fragments
were inserted between the BglII and PstI sites
in pEGFP-F, thus replacing the farsenylation
box-coding sequence downstream of the GFP
sequence. The resulting plasmids have been named
pCMV-GFPM148R and pCMV-GFPM149R.
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The P7.5 early/late poxviral promoter, issued
from pSC11 [7], was digested by XbaI-BamHI
and cloned into pBluescript-SK (Stratagene, Massy,
France). The resulting plasmid pBS-P7.5 was
digested by XmaI and KpnI to insert, under
P7.5 poxviral promoter, the entire GFP fusion
sequence of M148R or M149R, provided by
AgeI-KpnI digestion of pCMV-GFPM148R and
pCMV-GFPM149R, respectively. The resulting
plasmids are pBS-P7.5GFPM148R and pBS-
P7.5GFPM149R, respectively.
2.5. Confocal microscopy observations
BGMK cells were plated onto multichamber
slide ﬂasks (Falcon, Le Pont de Claix, France),
transfected with plasmid expressing GFP fusion
of M148R or M149R under P7.5 or CMV
promoter, with or without prior infection for
2h with MYXV deleted for the corresponding
gene. Twenty-four hours post-transfection (p.t.),
cells were ﬁxed with 4% paraformaldehyde in
PBS and permeabilized with 0.1% Triton X-
100. Cells were incubated with mouse anti-human
B23 antibodies (1/100; Sigma) or anti-MYXV
serum (1/500) in 0.05% Tween in PBS and then
with rhodamine RX coupled anti-mouse antibod-
ies (1/200; Jackson Immunoresearch, West Grove,
PA, USA) or CY-5 coupled anti-rabbit antibodies
(1/200; Immunotech, Villepinte, France), respec-
tively. Some samples were stained with TO-PRO-3
iodide (Invitrogen). Samples were observed with a
confocal LSM Olympus microscope. Multistaining
experiments were performed using the sequential
mode.
2.6. Construction of MYXV-M148R,
MYXV-M149R,
MYXV-M148RM149R,
and revertant viruses
Brieﬂy, inactivation of the target open reading
frames (M148R, M149R or both) was achieved
by homologous recombination in MYXV infected
RK13 cells, transfected with the appropriate
plasmid. The M149R gene, ampliﬁed by PCR
(using 5 M149RBamHI and 3 M149RPstI primers)
and cloned into the pGEM-T vector (Promega,
Charbonnieres, France) was inactivated by replac-
ing the SnaBI-BglII central region (785 bp) by the
LacZ gene, under the control of the late Vaccinia
virus promoter P11, issued from pSC11 [7]. After
homologous recombination in MYXV T1 infected
cells, MYXV- M149R mutant was screened for
blue plaque in the presence of X-Gal (5-bromo-4-
chloro-3-indolyl--d-galactopyranoside).
M148R gene, ampliﬁed by PCR (using
5 M148RBglII and 3 M148RPstI ) and cloned into
the pGEM-T expression vector (Promega), was
inactivated by replacing the SnaBI-EcoRV central
region (1051 bp) by the Ecogpt gene (Escherichia
coli xanthine-guanine phosphoribosyl transferase),
under the control of the P7.5 promoter issued from
the digest of pRBgpt [9]. After recombination in
MYXV infected RK13 cells, MYXV- M148R
mutants were selected by resistance to mycophe-
nolic acid in DMEM supplemented with 25g/mL
mycophenolic acid (MPA), 250g/mL xanthine
and HAT (Hypoxanthine Aminopterin Thymidine;
Sigma, 1/50).
The MYXV- M148R M149R was obtained
by transfecting MYXV- M149R infected RK13
cells with the plasmid containing the inactivated
form of M148R. MYXV- M148R M149R was
selected by resistance to mycophenolic acid.
Purity of all mutant viruses was veriﬁed by
PCR.
In order to engineer a revertant virus (MYXV-
rev), the native sequence including M148R and
M149R open reading frames was obtained by PCR
using 5 M148RBglII and 3 M149RPstI primers,
and cloned into pGEM-T. After recombina-
t i o ni nM Y X V -  M148R M149R-infected RK13
HGPRT− cells, MYXV-rev was obtained by reverse
Ecogpt selection using 6-thioguanine (5g/mL)
and by reverse white-blue screening.
2.7. Infection and virus growth curves
For growth analysis in rabbit PBMC, 6 × 106
cells were infected with T1, MYXV- M148R,
MYXV- M149R or MYXV- M148R M149R at
an m.o.i. of 1. For single-step analysis on RK13
and BGMK, 5 × 105 cells were infected with wild
type MYXV or mutant viruses at an m.o.i. of 4. For
multi-step analysis on RK13 and BGMK, 5 × 105
cells were infected with viruses at an m.o.i. of 0.01.
The inoculums were allowed to adsorb for 2h at
4 ◦C. Then, unabsorbed viruses were removed, and
cells were incubated in DMEM supplemented with
5% FCS. At different times p.i., cells were scraped,
frozen and virus titers were determined on RK13
cells.
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2.8. Infection of rabbits with wild-type MYXV,
MYXV-rev, MYXV-M148R,
MYXV-M149R and
MYXV-M148RM149R
Eight-week old male New Zealand White
rabbits were obtained from a local supplier and
housed in biocontainment facilities according to
the guidelines of the European Community Council
on Animal Care4. All procedures on animals
were performed by staff accredited by the French
Ministry of Agriculture and were designed to limit
animal pain and distress. Infections were performed
intradermally in the right ear with 5 × 103 PFU
of either virus. Rabbits were monitored daily for
clinical signs of myxomatosis. Rabbits that became
moribund were sacriﬁced with T61 (Distrivet,
Romainville, France) administered intravenously.
2.9. Histological examination
For histological studies, 6 rabbits were inocu-
lated with MYXV strain T1 and 6 were inocu-
lated with each mutant-virus described above. At 5,
8, and 13 days p.i., two animals from each group
were sacriﬁced. Two mock-infected rabbits were
sacriﬁced and used as controls. All animals were
subjected to complete post-mortem examination.
Tissue material from the injection site (ear [pri-
mary site]) and parotid lymph node (secondary site)
were taken and stored in 10% neutral formalin for
further analysis. After ﬁxation, tissues were rou-
tinely processed into parafﬁn blocks, sectioned at a
thickness of 4m, and stained with haematoxylin
and eosin for microscopic examination. Lesions
were assessed histologically and graded as minimal
(+), mild (++), moderate (+++), marked (++++) or
severe (+++++).
3. RESULTS
3.1. M148R and M149R are two ANK repeats
and F-box containing proteins
Depending on the software used for protein
analysis, up to 10 ANK repeats can be
identiﬁed in M148R, and up to 9 in M149R
(Fig. 1). The newly established PRANC
(Pox protein Repeats of Ankyrin C-terminal)
4 European Council directive 86/609/EEC, 24
November 1986.
domain, belonging to the F-box motif family,
is present in both proteins.
3.2. M148R and M149R are expressed
sequentially during the infection
Manual analysis, according to published
consensus promoter and terminator sequences,
revealed sequences consistent with a late
transcription of M148R. No sequence clearly
corresponding to early or late promoter was
found upstream of the ATG of M149R.
RT-PCR analysis of total RNA puriﬁed
from wild-type MYXV-infected cells demon-
strated that the M148R transcript was weakly
detectable as early as 2h p.i.. The expres-
sion of M148R increased up to 16h p.i. and
is totally inhibited in the presence of AraC
(Fig. 2, upper panel).
The M149R transcript was detectable as
early as 2h p.i., and could still be detected
at 16h p.i. (Fig. 2, middle panel). However,
the level of detected transcript was noticeably
lower following the treatment with AraC, as
opposed to what was observed with MNF
(M150R), control of early gene expression
(Fig. 2, lower panel). Since M148R, M149R
and MNF are organized in a cluster of
genes, temporally expressed in the reverse
sense of their location, one could inﬂuence
the expression of the others. Therefore, RT-
PCR analysis of expression of M148R and
M149R in T1 MNF-infected RK13 cells
was performed. MNF deletion affects neither
M148R nor M149R transcription (data not
shown). Likewise, deletion of M149R does not
affect M148R transcription.
3.3. M148R and M149R have different
subcellular localizations
To determine the subcellular localiza-
tion of each protein, plasmids expressing a
GFP-protein fusion (with M148R or M149R
fused downstream of the GFP, under CMV
promoter) were used to transfect BGMK cells.
Cells were examined by confocal microscopy
at 24h p.t.. As shown in Figure 3Aa, GFP-
M148R fusion is located in both the cytoplasm
and nucleus. The nuclear fraction of M148R
P a g e4o f1 4( page number not for citation purpose)M148R and M149R are MYXV’s virulence factors Vet. Res. (2009) 40:11
B
M148R
M149R
Figure 1. Functional domains of M148R and M149R Myxoma virus proteins. (A) Functional domains of
M148R and M149R proteins found by 3 online software: Pfam [11], REP [1] and SMART [14]. “trunc”
(truncated) indicates that only the second half of the repeat was identiﬁed. (B) Schematic representation of
M148R and M149R proteins. Gray boxes: ANK repeat; hatched: PRANC (Pox protein Repeats of Ankyrin
C-terminal) domain.
+ - T0 T 2 T 4 T 8 T 12 T 16 n.i  AraC 
M148R
M150R
M149R
Figure 2. Expression of M148R and M149R mRNA in cell culture. RK13 cells were infected with wild
type MYXV. At different times p.i., mRNA were extracted, subjected to reverse transcription using oligodT
primers, following which, PCR was performed using speciﬁc primers for M148R, M149R, or M150R. Lane
+, positive control, i.e. PCR on T1 DNA; lane –, negative control, i.e. PCR without template; lanes T0
through T16, cells infected with wild-type MYXV for 0, 2, 4, 8, 12, or 16h, respectively; lane n.i., mock-
infected cells; lane AraC, cells infected with wild-type MYXV for 16h and incubated with AraC at the time
of infection. T0 corresponds to RNA extractions performed after 1h of virus adsorption.
(page number not for citation purpose) Page 5 of 14Vet. Res. (2009) 40:11 S. Blanié et al.
GFP Anti-B23 MERGE
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pCMV-
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pCMV-
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pBS-P7.5
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GFP-M149R
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Figure 3. Cellular localization of M148R and M149R. (A) BGMK cells grown on coverslips were
transfected with pCMV-GFPM148R (a, b, c) or pCMV-GFPM149R (d, e, f). Cells were ﬁxed at 24h p.t.,
permeabilized, stained with anti-B23 antibody (red staining) and TO-PRO-3 iodide to detect nuclei (blue
staining), and analyzed by confocal microscopy with a 60× objective. Multistaining experiments were
performed using the sequential mode. (B) BGMK cells grown on coverslips were pBS-P7.5GFPM148R
(a, b, c) or pBS-P7.5GFPM149R (d, e, f) transfected, with prior 2h infection with the MYXV deleted for
the corresponding gene. At 24h p.t., cells were ﬁxed, permeabilized, stained with anti-MYXV serum (red
staining) and analyzed by confocal microscopy as previously indicated.
shows a nucleolar pattern, as conﬁrmed by
colocalization (Fig. 3Ac, yellow merge stain-
ing) with B23 (nucleophosmin, Fig. 3Ab, red
staining), a major multifunctional nucleolar
phosphoprotein. A punctuate pattern with
a uniform distribution in the cytoplasm
was observed with the GFP-M149R fusion
(Fig. 3Ad). It was not possible to show any
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colocalization with the endoplasmic retic-
ulum, early endosomes, or lysosome (data
not shown). Typical diffuse (cytoplasmic and
nuclear) green pattern was observed with the
control transfection with a GFP expressing
plasmid (data not shown).
The same patterns were observed in
an infectious context, with GFP-fusions
expressed under P7.5 poxviral promoter
(Fig.3B).Absence ofgreenstaininginBGMK
transfected with pBS-7.5GFPM148R or pBS-
7.5GFPM149R without infectious context
conﬁrmed that fusion expression under the
P7.5 promoter requires MYXV infection (data
not shown).
3.4. M148R and M149R are not essential for
replication in classical MYXV permissive
cells
The role of M148R and M149R in
the replication of MYXV was evaluated
by engineering mutant viruses deleted
in either M148R (MYXV- M148R),
or M149R (MYXV- M149R), or both
(MYXV- M148R M149R). The capacity of
replication of mutant viruses in cultured cell
lines (RK13 and BGMK) and primary cells
(PBMC) was tested. Experiments showed that
neither deletion of M148R, nor M149R, nor
both, induced modiﬁcation in virus replication
in RK13, BGMK, or PBMC (Fig. 4A). In
order to examine mutant viruses spread in
cultured cells, multi-step experiments on
RK13 and BGMK cells were performed. No
defects in the ability of mutant viruses to
spread in these cells were observed (Fig. 4B).
3.5. M148R and M149R are new MYXV
virulence factors in European rabbits
To evaluate the role of M148R and
M149R in the pathobiology of MYXV,
European rabbits were inoculated intrader-
mally with either wild type MYXV strain
T1, MYXV- M148R, MYXV- M149R,
MYXV- M148R M149R, or MYXV-rev
(control of phenotype speciﬁcity). The clinical
course of infection was monitored daily for
21 days. Data are summarized in Table I.
Rabbits infected with the T1 strain developed
typical clinical myxomatosis, characterized
by the development at day 4 p.i. of a large red
and raised primary skin lesion at the inocu-
lation site. At day 8 p.i., secondary lesions
appeared on ears, eyelids, nose, back and
subsequentially over the entire body. Conjunc-
tivas inﬂammation and initially serous, later
mucopurulent (day 10 p.i.) discharge from
the nose and eyes followed, accompanied by
respiratory distress (day 12 p.i.). Rabbits died
within two weeks due to bacterial infection of
the respiratory tract. The same clinical course
of infection was observed with MYXV-rev
infected rabbits.
Clinicalobservationsrevealedthatinfection
with the MYXV- M148R, MYXV- M149R
and MYXV- M148R M149R mutants is
clearly attenuated compared to wild type
virusinfection.TheMYXV- M148Rinfected
group showed a delay of three days in
the onset of clinical signs, with a mortality
rate of 40%. They suffered from only light
infections of conjunctivas and respiratory
tract. MYXV- M149R induced a delay of
4 days on the onset of secondary lesions,
which were less numerous and restricted to
the face area. All infected animals recovered.
Finally, all rabbits infected with the MYXV-
 M148R M149R showed few clinical signs,
except for secondary lesions which appeared
earlier (day 6 p.i.) than usual, were smaller and
more numerous, and ﬁnally resorbed rapidly.
All rabbits recovered.
3.6. Histological analysis of lesions from wild
type and mutant MYXV
Detailed histological examination of tissue
material from both the primary (ear) and
secondary (parotid lymph node) infection sites
was carried out at various times during the
courseofinfection.Theresultsofthecomplete
analysis are summarized in Table II.
At day 5 p.i., the injection sites of wild-type
MYXV and mutant viruses demonstrated sim-
ilar microscopic lesions, i.e. perivascular der-
matitis with focal edema, interstitial mucinosis
and inﬂammatory inﬁltrates mainly composed
of heterophils. In the parotid lymph node,
both mutant and wild-type viruses induced a
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Figure 4. Growth kinetics of wild-type and mutant viruses. (A) To evaluate viruses in vitro replication, cell
lines (RK13 and BGMK) and primary cells (PBMC) were respectively infected at m.o.i. 4 and m.o.i. 1,
with wild-type MYXV (thin solid line ()), MYXV- M148R (bold dashed line ()), MYXV- M149R
(thin dashed line ()) or MYXV- M148R M149R (bold solid line (×)). Virus titers were determined at
different times p.i. on RK13 cells. Results are shown as means ± SEM (triplicate). (B) To examine virus
spread, cells were infected at a low m.o.i. (m.o.i. = 0.01). Virus titers were determined at different times p.i.
as indicated above. Results are shown as means ± SEM (duplicate).
lymphadenitis with lymphoid hyperplasia,
focal histiocytosis and moderate inﬁltration by
heterophils.
At day 8 p.i., the injection sites of
wild-type MYXV, MYXV- M148R and
MYXV- M148R M149R showed a differ-
ence in the nature of inﬂammatory inﬁltrates
in the myxomas. With wild-type MYXV
(as with the MYXV- M149R, to a lesser
extent), heterophils still composed the main
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cellular population. By contrast, for the
lesions associated with the MYXV- M148R
and MYXV- M148R M149R, sequential
inﬂammatory cellular reactions progressed
more rapidly, as attested by the presence of
inﬁltrates with a majority of mononuclear
cells (histiocytes and lymphocytes). In the
parotid lymph node, a lymphadenitis with
lymphoid hyperplasia and focal histiocytosis
was observed for all viruses. As for the
primary site, inﬁltration by heterophils was
more pronounced for wild-type MYXV and
MYXV- M149R than for MYXV- M148R
and MYXV- M148R M149R. The presence
of activated ﬁbroblasts with interstitial muci-
nosis was greater with wild-type MYXV than
with all other viruses.
At day 13 p.i., the injection sites of
wild-type MYXV, MYXV- M148R and
MYXV- M148R M149R still showed a
difference in the nature of inﬂammatory inﬁl-
trates in the myxomas. With wild-type MYXV
as with MYXV- M149R, the proportions
of heterophils and mononuclear cells
(histiocytes, lymphocytes, and plasmo-
cytes) tended to become counterbalanced. For
the lesions associated with MYXV- M148R
and MYXV- M148R M149R, mononuclear
cells were markedly predominant. The number
of activated ﬁbroblasts and the amount of
interstitial mucinosis were greater with wild-
type MYXV than with all other viruses. In the
parotid lymph node, both mutant and wild-
type viruses showed a lymphadenitis with
lymphoid hyperplasia and focal histiocytosis.
From these observations, we can conclude
that the inﬂammatory reaction is more rapidly
resolved for MYXV- M148R and MYXV-
 M148R M149R (at day 8 p.i., mononuclear
cells were predominant) than for wild-
type MYXV and MYXV- M149R. Another
difference was the very high level of cellular
density of activated ﬁbroblasts and interstitial
mucinosis in lesions induced by wild-type
MYXV at day 13 p.i. in comparison with
lesions induced by other viruses.
4. DISCUSSION
This study is the ﬁrst characterization of
M148R and M149R, 2 of the 4 ANK repeat
proteins encoded by MYXV. We demonstrate
that M148R and M149R are virulence factors
of MYXV.
Our experiments provide new data on
M148R and M149R expression. They were
ﬁrst described as early genes coding for
cytoplasmic proteins with 9 ANK repeats
and 4 putative transmembrane regions and
with 8 ANK repeats, respectively [5]. We
show that M148R is expressed as a late
gene and that up to 10 ANK repeats can be
identiﬁed in the protein. We also show that
M149R is expressed earlier than M148R, is
partially inhibited by AraC and that up to 9
ANK repeats can be identiﬁed in the protein.
The observed decrease in M149R expression
level, due to AraC treatment, suggests that
M149R expression level partially relies on
viral DNA replication. No sequence clearly
corresponding to early or late promoters was
found upstream of the ATG of M149R.
However, the GG dinucleotide can be found
immediately after a TAATAT motif (a part of
the ATG), compatible with an intermediate
signal. On the contrary, an early transcription
termination signal is present two nucleotides
upstream of the stop codon. Interestingly, the
M148R and M149R form, with MNF, a cluster
of genes coding for ANK repeat proteins,
temporally expressed in the reverse sense of
their location, without a transcriptional effect
from the ones on the others.
M148R and M149R were predicted to be
cytoplasmic proteins [5]. This was conﬁrmed
for M149R. In contrast we show that
M148R is located in both the cytoplasm and
nucleolus, with or without a viral context.
This suggests that no viral cofactor is required
to address M148R to the nucleolus. Though
no classical nuclear localization signal (NLS)
was identiﬁed in M148R, it has been shown
that ANK repeats can be used as a non
typical NLS [24]. This has been veriﬁed for
MNF since deletion of its eighth ANK repeat
prevents MNF translocation to the nucleus [6].
This may also be the case for M148R.
As initial studies on poxviral ANK repeat
proteins, such as Vaccinia virus K1L [3,
22] and M-T5 [18], have demonstrated they
were involved in cell tropism or host range
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functions, the role of M148R and M149R
in the replication of MYXV was evaluated.
We show that deletion of M148R, M149R, or
both, does not induce modiﬁcation in virus
replication in rabbit cells (ﬁbroblast cell lines
or PBMC) or in BGMK cells. Thus M148R
and M149R do not seem to be implicated in
either cell tropism or host range functions,
based upon the cell lines examined.
However, we show that single deletion of
M148R or M149R induces a delay in the
onset of blepharitis and respiratory infections,
an increase of survival time and a dramatic
decrease in mortality rate. Moreover, MYXV-
 M148R M149R infected rabbits expressed
only moderate blepharitis, no signs of respi-
ratory infection and totally recovered. Since
there are no signiﬁcant differences between
virus replication in rabbit lymphocytes, we
can conclude that the observed delay in clin-
ical sign onset and the attenuated phenotype
cannot be explained by impairment of virus
diffusion after intradermal infection. MYXV-
 M149R induced few secondary lesions that
appeared later than with the other viruses
and were located on the face only. Sur-
prisingly, MYXV- M148R M149R infected
rabbits had earlier, smaller and more numer-
ous secondary lesions that resorbed faster than
rabbits infected with other viruses, includ-
ing the wild type one. Therefore, clinical
signs observed after infection with MYXV-
 M148R M149R seem to be different from
the simple addition effect of attenuated phe-
notypes induced by each single deleted virus.
ThissuggeststhatM148R andM149Rmayact
in synergy.
Histological analysis of the primary myx-
oma (inoculation site) and parotid lymph node
showed that deletion of the M148R gene
allowed a quicker resolution of the inﬂamma-
tion. Therefore, like MNF, M148R is located
in the cell nucleus and seems to play a role
in the subverting of inﬂammatory response by
MYXV. However, deletion of MNF induces
more drastic attenuation than M148R deletion
and they do not seem to be located in the same
subnuclear compartment [6]. Indeed M148R
is located in part in the nucleolus of infected
cells. For many years, the exclusive function
of the nucleolus was thought to be riboso-
mal rRNA synthesis and ribosome biogene-
sis. However, the nucleolus has been recently
implicated in many aspects of cell biology
that include functions such as gene silenc-
ing, senescence and cell cycle regulation [19–
21]. Numerous viruses encode proteins that
interfere with the nucleolus, such as EBNA5
of the Epstein Barr virus [30], ICP27 of the
Herpes simplex virus [16] or Rev and Tat of
HIV-1 [8,10,26]. However, reasons for target-
ing host-cell nucleoli and mechanisms used to
subvert nucleolar functions are usually specu-
lative. It may favor viral transcription, transla-
tion or alter the cell cycle in order to promote
virus replication.
If ANK repeat proteins are involved in
a large set of functions, the conserved role
of the ANK motif is to be a mediator of
speciﬁc protein-protein interactions. As the
majority of ANK repeats poxviral proteins,
M148R and M149R have an F-box sequence
at the C-terminus. Both motifs are rare among
viruses but are abundant in poxviruses [2,
17]. Moreover, poxviral F-box motifs are
not typical compared to those found in
eukaryotes for which F-box motifs are located
at the N-terminus of the protein and are
associated with WD repeats and leucine-rich
repeats as classical protein-protein interaction
domain [12]. F-box proteins are involved
in ubiquitin-dependent proteolysis in cell
cycle regulation and signal transduction.
They are recognition subunits of ubiquitin
ligase complexes where the F-box domain
binds to ubiquitin ligase and where protein-
protein interaction domain binds the substrate
protein [13]. Based on these observations,
Mercer et al. proposed that poxviral ANK-F-
box proteins work as described, using ANK
repeats to interact with the target protein
and to direct its ubiquitination [17]. It was
conﬁrmed for the VACV 68k protein [28]
and for ﬁve Orf virus proteins [27]. All these
ANK-F-box poxviral proteins co-precipitated
with Skp1 and Cullin-1, two components of
SCF1 ubiquitin ligase complex. All these
proteins have different localizations such
as cytoplasmic, nuclear, perinucleolar, but
none has been shown to be nucleolar as
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is M148R. We attempted to co-precipitate
Cullin-1 in BGMK cells transfected with the
GFP fusion of M148R and M149R, under
CMV promoter. We succeeded in precipitating
the fusion proteins, but failed to demonstrate
any interaction with neither Cullin-1 nor
Skp1 (data not shown). These experiments
are not conclusive enough to totally exclude
an interaction between these proteins. New
experiments should be done in conditions
of infection, in primate and rabbit cells.
Moreover, possible interactions with other
partners known to interact with some ANK-
F-box poxviral proteins such as proteins of
Akt pathway [33] or mainly NFB signaling
pathway, as is the case for K1L [25] and
MNF [6], need to be explored.
Acknowledgements. We thank Brigitte Peralta and
Josyane Loupias for excellent technical assistance.
S. Blanié was supported by funds from the French
Ministry of Research and Technology.
REFERENCES
[1] Andrade M.A., Ponting C.P., Gibson T.J., Bork P.,
Homology-based method for identiﬁcation of protein
repeats using statistical signiﬁcance estimates, J. Mol.
Biol. (2000) 298:521–537.
[2] Bork P., Hundreds of ankyrin-like repeats in
functionally diverse proteins: mobile modules that
cross phyla horizontally?,Proteins (1993) 17:363–374.
[3] Bradley R.R., Terajima M., Vaccinia virus K1L
protein mediates host-range function in RK-13
cells via ankyrin repeat and may interact with a
cellular GTPase-activating protein, Virus Res. (2005)
114:104–112.
[4] Broyles S.S., Vaccinia virus transcription, J. Gen.
Virol. (2003) 84:2293–2303.
[5] Cameron C., Hota-Mitchell S., Chen L., Barrett
J., Cao J.X., Macaulay C., et al., The complete DNA
sequence of myxoma virus, Virology (1999) 264:298–
318.
[6] Camus-Bouclainville C., Fiette L., Bouchiha S.,
Pignolet B., Counor D., Filipe C., et al., A virulence
factor of myxoma virus colocalizes with NF-kappaB in
the nucleus and interferes with inﬂammation, J. Virol.
(2004) 78:2510–2516.
[7] Chakrabarti S., Brechling K., Moss B., Vac-
cinia virus expression vector: coexpression of beta-
galactosidaseprovidesvisualscreeningofrecombinant
virus plaques, Mol. Cell. Biol. (1985) 5:3403–3409.
[8] Dundr M., Leno G.H., Hammarskjold M.L.,
Rekosh D., Helga-Maria C., Olson M.O., The roles
of nucleolar structure and function in the subcellular
location of the HIV-1 Rev protein, J. Cell Sci. (1995)
108:2811–2823.
[9] Falkner F.G., Moss B., Transient dominant
selection of recombinant vaccinia viruses, J. Virol.
(1990) 64:3108–3111.
[10] Fankhauser C., Izaurralde E., Adachi Y., Wing-
ﬁeld P., Laemmli U.K., Speciﬁc complex of human
immunodeﬁciency virus type 1 rev and nucleolar B23
proteins: dissociation by the Rev response element,
Mol. Cell. Biol. (1991) 11:2567–2575.
[11] Finn R.D., Tate J., Mistry J., Coggill P.C., Sam-
mut S.J., Hotz H.R., et al., The Pfam protein families
database, Nucleic Acids Res. (2008) 36:D281–288.
[12] Jin J., Cardozo T., Lovering R.C., Elledge S.J.,
Pagano M., Harper J.W., Systematic analysis and
nomenclature of mammalian F-box proteins, Genes
Dev. (2004) 18:2573–2580.
[13] Jin J., Ang X.L., Shirogane T., Wade Harper
J., Identiﬁcation of substrates for F-box proteins,
Methods Enzymol. (2005) 399:287–309.
[14] Letunic I., Copley R.R., Pils B., Pinkert S.,
Schultz J., Bork P., SMART 5: domains in the context
of genomes and networks, Nucleic Acids Res. (2006)
34:D257–D260.
[15] Marck C., ‘DNA Strider’: a ‘C’ program for the
fast analysis of DNA and protein sequences on the
Apple Macintosh family of computers, Nucleic Acids
Res. (1988) 16:1829–1836.
[16] Mears W.E., Lam V., Rice S.A., Identiﬁcation
of nuclear and nucleolar localization signals in the
herpes simplex virus regulatory protein ICP27, J.
Virol. (1995) 69:935–947.
[17] Mercer A.A., Fleming S.B., Ueda N., F-box-like
domains are present in most poxvirus ankyrin repeat
proteins, Virus Genes (2005) 31:127–133.
[18] Mossman K., Lee S.F., Barry M., Boshkov L.,
McFadden G., Disruption of M-T5, a novel myxoma
virus gene member of poxvirus host range superfamily,
results in dramatic attenuation of myxomatosis in
infected European rabbits, J. Virol. (1996) 70:4394–
4410.
[19] Olson M.O., Dundr M., Szebeni A., The
nucleolus: an old factory with unexpected capabilities,
Trends Cell Biol. (2000) 10:189–196.
[20] Olson M.O., Hingorani K., Szebeni A., Conven-
tional and nonconventional roles of the nucleolus, Int.
Rev. Cytol. (2002) 219:199–266.
[21] Pederson T., The plurifunctional nucleolus,
Nucleic Acids Res. (1998) 26:3871–3876.
(page number not for citation purpose)P a g e1 3o f1 4Vet. Res. (2009) 40:11 S. Blanié et al.
[22] Perkus M.E., Goebel S.J., Davis S.W., Johnson
G.P., Limbach K., Norton E.K., Paoletti E., Vaccinia
virus host range genes, Virology (1990) 179:276–286.
[23] Pignolet B., Boullier S., Gelﬁ J., Bozzetti M.,
Russo P., Foulon E., et al., Safety and immunogenicity
of myxoma virus as a new viral vector for small
ruminants, J. Gen. Virol. (2008) 89:1371–1379.
[24] Sachdev S., Hoffmann A., Hannink M., Nuclear
localization of IkappaB alpha is mediated by the
second ankyrin repeat: the IkappaB alpha ankyrin
repeatsdeﬁneanovelclassofcis-actingnuclearimport
sequences, Mol. Cell. Biol. (1998) 18:2524–2534.
[25] Shisler J.L., Jin X.L., The vaccinia virus K1L
gene product inhibits host NF-kappaB activation by
preventing IkappaBalpha degradation, J. Virol. (2004)
78:3553–3560.
[26] Siomi H., Shida H., Maki M., Hatanaka M.,
Effects of a highly basic region of human immuno-
deﬁciency virus Tat protein on nucleolar localization,
J. Virol. (1990) 64:1803–1807.
[27] Sonnberg S., Seet B.T., Pawson T., Fleming S.B.,
Mercer A.A., Poxvirus ankyrin repeat proteins are
a unique class of F-box proteins that associate with
cellular SCF1 ubiquitin ligase complexes, Proc. Natl.
Acad. Sci. USA (2008) 105:10955–10960.
[28] Sperling K.M., Schwantes A., Schnierle B.S.,
Sutter G., The highly conserved orthopoxvirus 68k
ankyrin-like protein is part of a cellular SCF ubiquitin
ligase complex, Virology (2008) 374:234–239.
[29] Stanford M.M., Werden S.J., McFadden G.,
Myxoma virus in the European rabbit: interactions
between the virus and its susceptible host, Vet. Res.
(2007) 38:299–318.
[30] Szekely L., Jiang W.Q., Pokrovskaja K., Wiman
K.G., Klein G., Ringertz N., Reversible nucleolar
translocation of Epstein-Barr virus-encoded EBNA-5
and hsp70 proteins after exposure to heat shock or
cell density congestion, J. Gen. Virol. (1995) 76:2423–
2432.
[31] Upton C., Macen J.L., McFadden G., Mapping
and sequencing of a gene from myxoma virus that
is related to those encoding epidermal growth factor
and transforming growth factor alpha, J. Virol. (1987)
61:1271–1275.
[32] Upton C., Macen J.L., Maranchuk R.A., DeLange
A.M., McFadden G., Tumorigenic poxviruses: ﬁne
analysis of the recombination junctions in malignant
rabbit ﬁbroma virus, a recombinant between Shope
ﬁbroma virus and myxoma virus, Virology (1988)
166:229–239.
[33] Werden S.J., Barrett J.W., Wang G., Stanford
M.M., McFadden G., M-T5, the ankyrin repeat, host
range protein of myxoma virus, activates Akt and can
be functionally replaced by cellular PIKE-A, J. Virol.
(2007) 81:2340–2348.
[34] Werden S.J., McFadden G., The role of cell
signaling in poxvirus tropism: the case of the M-
T5 host range protein of myxoma virus, Biochim.
Biophys. Acta (2008) 1784:228–237.
[35] Wheeler D.L., Barrett T., Benson D.A., Bryant
S.H., Canese K., Chetvernin V., et al., Database
resources of the National Center for Biotechnology
Information, Nucleic Acids Res. (2008) 36:D13–D21.
Page 14 of 14 (page number not for citation purpose)